wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26742078-0F96D73F-B51E-4012-A749-C68DF931B922
Q26742078-0F96D73F-B51E-4012-A749-C68DF931B922
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26742078-0F96D73F-B51E-4012-A749-C68DF931B922
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
P2860
Q26742078-0F96D73F-B51E-4012-A749-C68DF931B922
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26742078-0F96D73F-B51E-4012-A749-C68DF931B922
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98ceb68b0c688ca944ac10f997e36dee03760aea
P2860
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.